- MSKCC is profiled in a New York Times article about major academic medical centers in New York and around the country that are spending and recruiting heavily on genomic sequencing programs.
- Researchers from Cornell and MSKCC have published results of a study that revealed that spongelike nanoparticles whose pores can be filled with drugs may offer the promise of drug delivery to specific targets in the body.
- Genetically engineered immune cells can drive an aggressive type of leukemia into retreat, an MSKCC clinical trial suggests.
- Charles Sawyers of MSKCC is quoted in a Nature article advocating for cancer researchers to focus on single-subject, or ‘n-of-1’, studies that could offer new insights into cancer.
- A new study published in the British Medical Journal from researchers at MSKCC suggest that aside from men with a history of prostate cancer, other groups at high risk for the disease may be identified with a single PSA test when they are in their 40s.